Company Summary:
Tessera Therapeutics is pioneering Gene Writing™— a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Position Summary:
The Synthetic Biology group is seeking a Principal Scientist/Associate Director. The role will help to lead and execute the engineering and development of novel gene editing technologies using systems biology tools in mammalian cells, directly furthering gene writers and rewriters for therapeutic deployment. This individual will join a collaborative team and have high growth potential.
Key Responsibilities:
Basic Qualifications:
Preferred Qualifications:
More About Flagship Pioneering
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $50B in aggregate value. To date, Flagship has deployed over $2.2B in capital toward the founding and growth of its pioneering companies alongside more than $18B of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics (NASDAQ: FHTX), Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics (NASDAQ: MCRB), and Sigilon Therapeutics (NASDAQ: SGTX).
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
Healthcare Without Rival We are currently looking for afull-time Registered Nurse (RN)to join our team at our workplace wellness center...
Apply For This JobWho We Are: iAnthus Capital Management is a multi-state operator, encompassing the full spectrum of cannabis enterprises, from cultivation to...
Apply For This JobThe Role: Reporting to the Associate Director of Quality Control Stability, the Quality Control Stability Specialist will be responsible for...
Apply For This JobThe Role: Moderna is seeking a motivated and energetic Program Leader for our Oncology programs to drive Cancer Vaccine specific...
Apply For This JobWrite Label is seeking a full-time Creative Manager who will work closely with the Director of Editorial to ensure the...
Apply For This JobLinkedIn is the world’s largest professional network, built to help members of all backgrounds and experiences achieve more in their...
Apply For This Job